Inventor
KAPLAN MURRAY A
US44 patents
⚠️ This page may combine multiple inventors who share the name “KAPLAN MURRAY A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS CO
34 patentsUS4451447AMay 29, 1984
Pharmaceutical formulations
BRISTOL MYERS CO117 citations96
US4322391AMar 30, 1982
Process for the preparation of microcrystalline cisplatin
BRISTOL MYERS CO30 citations92
US4161595AJul 17, 1979
Levulinic acid salt
BRISTOL MYERS CO37 citations92
US4100346AJul 11, 1978
Certain 7(o-amino-methyl- or methylaminomethylphenyl- or cyclohexadienyl- or thienylacetamide)-3[1-carboxymethyl-(or ethyl- or propyl-)-tetrazol-5-ylthiomethyl]-3-cephem-4-carboxylic acids
BRISTOL MYERS CO34 citations92
US4910301AMar 20, 1990
Cefepime cephalosporin salts
BRISTOL MYERS CO26 citations91
US4322362AMar 30, 1982
Salts of 2-hydroxymalonate platinum complexes
BRISTOL MYERS CO22 citations82
US4302446ANov 24, 1981
Pharmaceutical compositions
BRISTOL MYERS CO28 citations82
US4754030AJun 28, 1988
Cefbuperazone crystalline triethylamine salt
BRISTOL MYERS CO24 citations81
US5095011AMar 10, 1992
Lyophilized cefepime dihydrochloride for parenteral use
BRISTOL MYERS CO20 citations80
US4927638AMay 22, 1990
Etoposide solutions
BRISTOL MYERS CO21 citations76
US4808617AFeb 28, 1989
Lyophilized or precipitated cephalosporin zwitterion and salt combination
BRISTOL MYERS CO13 citations73
US4772589ASep 20, 1988
Etoposide solution in NMP
BRISTOL MYERS CO14 citations73
US4091213AMay 23, 1978
7-Cyclizedamino-3-heterothiomethyl cephalosporin derivatives
BRISTOL MYERS CO9 citations73
US4360523ANov 23, 1982
Pharmaceutical formulations of 4'-(9-acridinylamino)-methanesulfon-m-anisidide
BRISTOL MYERS CO9 citations71
US4727070AFeb 23, 1988
3-Propenzl cephalosporin isomer separation process and derivative
BRISTOL MYERS CO18 citations70
US4663458AMay 5, 1987
Water soluble salt composition of m-AMSA
BRISTOL MYERS CO4 citations63
US4626541ADec 2, 1986
Water soluble salt composition of m-AMSA
BRISTOL MYERS CO2 citations63
US4994271AFeb 19, 1991
BMY-40800 antitumor antibiotics
BRISTOL MYERS CO2 citations62
US4680389AJul 14, 1987
Temperature stable crystalline di(1-methyl-2-pyrralidinone) and di(N-formylpyrrolidine) adducts of cephalosporin derivatives
BRISTOL MYERS CO3 citations62
US4416874ANov 22, 1983
Injectable compositions of BBM-928A
BRISTOL MYERS CO3 citations62
US4335244AJun 15, 1982
Monolactate salts of 4'-(9-acridinylamino)methanesulfon-m-anisidide
BRISTOL MYERS CO4 citations62
US4297489AOct 27, 1981
7-α-Amino-substituted acylamino-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acids
BRISTOL MYERS CO2 citations62
US4182863AJan 8, 1980
7-Amino-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
BRISTOL MYERS CO4 citations62
US4172196AOct 23, 1979
Certain 7-α-substituted-α-hydroxyacetamido-3-(1-carboxymethyltetrazol-5-yl-thiomethyl)-3-cephem-4-carboxylic acids
BRISTOL MYERS CO3 citations62
US4064345ADec 20, 1977
Cephalosporins derivatives 7-cyclized α-amino-3-heterothio
BRISTOL MYERS CO2 citations62
US4994451AFeb 19, 1991
Cephalosporin salts and injectable compositions
BRISTOL MYERS CO6 citations61
US4180658ADec 25, 1979
7[-2-Alkoxyamino(acetamido)]cephalosporin derivatives
BRISTOL MYERS CO2 citations61
US4425348AJan 10, 1984
Antitumor compositions
BRISTOL MYERS CO3 citations60
US4946689AAug 7, 1990
Concentrated, stabilized cis-diamminedinitratoplatinum solutions for conversion to cisplatin
BRISTOL MYERS CO2 citations57
US4639528AJan 27, 1987
Crystalline form of 7-(dimethylaminomethylene-amino-9a-methoxymitosane
BRISTOL MYERS CO0 citations52
US4061862ADec 6, 1977
Derivatives of 7-(cyclized)phenylglycyl-3-triazolo-thio methyl cephalosporin
BRISTOL MYERS CO0 citations51
US4026888AMay 31, 1977
Certain derivatives of particular 3-thiolated cephalosporins
BRISTOL MYERS CO1 citations51
US5036010AJul 30, 1991
BMY-40800 antitumor antibiotics
BRISTOL MYERS CO1 citations48
US4792566ADec 20, 1988
In-vial deposition of 7-(dimethylaminomethylene)amino-9α-methoxymitosane
BRISTOL MYERS CO1 citations46
BRISTOL MYERS SQUIBB CO
10 patentsUS5646176AJul 8, 1997
Phosphonooxymethyl ethers of taxane derivatives
BRISTOL MYERS SQUIBB CO104 citations97
US6455575B2Sep 24, 2002
Phosphonooxymethyl ethers of taxane derivatives
BRISTOL MYERS SQUIBB CO7 citations73
US6207650B1Mar 27, 2001
Antiviral, highly water soluble, stable, crystalline salts of 2′, 3′-dideoxyinosine, 2′, 3′-dideoxy-2′, 3′-didehydrothymidine and 2′, 3′-dideoxy-2′-fluoroinosine
BRISTOL MYERS SQUIBB CO7 citations73
US5034397AJul 23, 1991
Stable, water soluble salt compositions of M-AMSA in 1-methyl-2-pyrrolidinone
BRISTOL MYERS SQUIBB CO7 citations73
US5244891ASep 14, 1993
Injectable compositions of cefepime dihydrochloride hydrate
BRISTOL MYERS SQUIBB CO11 citations72
US5455270AOct 3, 1995
Stabilized solutions of platinum(II) antitumor agents
BRISTOL MYERS SQUIBB CO13 citations68
US5608048AMar 4, 1997
d4 T polymorphic Form 1 process
BRISTOL MYERS SQUIBB CO9 citations65
US5401842AMar 28, 1995
Injectable compositions of a cephalosporin dihydrate salt
BRISTOL MYERS SQUIBB CO3 citations60
US5196555AMar 23, 1993
Water and solvent soluble axial hydroxy and mono- and di- carboxylic acid derivatives having high tumor activity
BRISTOL MYERS SQUIBB CO4 citations58
US5391729AFeb 21, 1995
Crystalline dihydrate of a cephalosporin salt
BRISTOL MYERS SQUIBB CO1 citations48